A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria

Diabetes

Volumn 49, Issue 3, 2000, Pages 521-524

  De Cosmo, Salvatore ^a   Argiolas, Alessandra ^a   Miscio, Giuseppe ^a   Thomas, Stephen ^d   Piras, Giampiero P ^b   Trevisan, Roberto ^e   Cavallo Perin, Paolo ^e   Bacci, Simonetta ^a   Zucaro, Luigi ^a   Margaglione, Maurizio ^a   Frittitta, Lucia ^c   Pizzuti, Antonio ^a   Tassi, Vittorio ^a   Viberti, Giancarlo C ^d   Trischitta, Vincenzo ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b BROTZU HOSPITAL   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d GUY S HOSPITAL   (United Kingdom)

^e IRCCS CSS ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA;

EID: 0034048785     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.3.521     Document Type: Article

References (25)

1. Mogensen CE: Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia 42:263-285, 1999
2. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med 339:1448-1456, 1998
3. Alaveras AEG, Thomas H, Sagriotis A, Viberti GC: Promoters of progression of diabetic nephropathy: the relative roles of blood glucose and blood pressure control. Nephrol Dial Transplant 12(Suppl. 2):71-74, 1997
4. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
5. Krolewki AS, Laffe LMB, Krolewski M, Quinn M, Warram JH: Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 332:1251-1255, 1995
6. Parving H-H, Jacobsen P, Tarnow L, Rossing L, Lecerfe L, Poirier O, Cambien F: Effect of deletion polymorphism of angiotensin-converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin-converting enzyme: observational follow-up study. BMJ 313:591-593, 1996
7. Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viberti G: Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 342:883-887, 1993
8. De Cosmo S, Bacci S, Piras GP, Cignarelli M, Placentino G, Margaglione M, Colaizzo D, Di Minno G, Giorgino R, Liuzzi A, Viberti GC: High prevalence of risk factor for cardiovascular disease in parents of IDDM patients with albuminuria. Diabetologia 40:1191-1196, 1997
9. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1998
10. Virkamaki A, Ueki K, Kahn CR: Protein-protein interaction in insulin signalling and the molecular mechanisms of insulin resistance. J Clin Invest 103:931-943, 1999
11. Trischitta V, Frittitta L, Vigneri R: Early molecular defects in human insulin resistance: studies in healthy subjects with low insulin sensitivity. Diabetes Metab Rev 13:147-162, 1997
12. Maddux BA, Sbraccia P, Kumakura S, Sasson S, Youngren J, Fisher A, Spencer S, Grupe A, Henzel W, Stewart TA, Reaven GM, Goldfine ID: Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus. Nature 373:448-451, 1995
13. Frittitta L, Youngren J, Vigneri R, Maddux BA, Trischitta V, Goldfine ID: PC-1 content in skeletal muscle of non-obese, non-diabetic subjects: relationship to insulin receptor tyrosine-kinase activity and whole body insulin sensitivity. Diabetologia 39:1190-1195, 1996
14. Youngren J, Maddux BA, Sasson S, Sbraccia P, Tapscott EB, Swanson MS, Dohm LG, Goldfine ID: Skeletal muscle content of membrane glycoprotein PC-1 in obesity. Diabetes 45:1324-1328, 1996
15. Frittitta L, Youngren J, Sbraccia P, D'Adamo M, Buongiorno A, Vigneri R, Goldfine ID, Trischitta V: Increased adipose tissue PC-1 protein content, but not tumor necrosis factor-α gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity. Diabetologia 40:282-289, 1997
16. Frittitta L, Spampinato D, Solini A, Nosadini R, Goldfine ID, Vigneri R, Trischitta V: Elevated PC-1 content in cultured skin fibroblasts correlates with decreased in vivo and in vitro insulin action in nondiabetic subjects Diabetes 47:1095-1100, 1998
17. Pizzuti A, Frittitta L, Argiolas A, Baratta R, Goldfine ID, Bozzali M, Ercolino T, Scarlato G, Iacoviello L, Vigneri R, Tassi V, Trischitta V: A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes 48:1881-1884, 1999
18. Cockroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
19. Viberti GC, Bilous RW, Mackintosh D, Bending JJ, Keen H: Long-term correction of hyperglycemia and progression of renal failure in insulin dependent diabetes. Br Med J 286:598-602, 1983
20. Kuramoto N, Iizuka T, Ito H, Yagui K, Omura M, Nozaki O, Nishikawa T, Tsuchida H, Makino H, Saito Y, Kanatsuka A: Effect of ACE gene on diabetic nephropathy in NIDDM patients with insulin resistance. Am J Kidney Dis 33:276-281, 1999
21. Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C, Dusselier L, Kahal Z, Chaillous L, Halimi S, Muller A, Sackmann H, Bauduceau B, Bled F, Passa P, Alhene-Gelas F: Contribution of genetic polymorphism of the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. J Clin Invest 99:1585-1595, 1997
22. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i:307-310, 1986
23. De Cosmo S, Margaglione M, Tassi V, Garrubba M, Thomas S, Olivetti C, Piras GP, Trevisan R, Vedovato M, Cavallo Perin P, Bacci S, Colaizzo D, Cisternino C, Zucaro L, Di Minno G, Trischitta V, Viberti GC: ACE, PAI-1, decorin and Werner helicase genes are not associated with the development of renal disease in European patients witli type 1 diabetes. Diabetes Metab Res Rev 15:247-253, 1999
24. De Cosmo S, Tassi V, Margaglione M, Thomas S, Piras GP, Trevisan K, Cavallo Perin P, Bacci S, Colaizzo D, Cisternino D, Di Minno G, Trischitta V, Viberti GC: Genetic factors in the development and progression of renal disease in type 1 diabetic patients (Abstract). Diabetologia 41 (Suppl. 1) A293, 1998
25. Argiolas A, De Cosmo S, Tassi V, Margaglione M, Thomas S, Piras GP, Trevisan R, Cavallo Perin P, Bacci S, Colaizzo D, Cisternino C, Di Minno G, Trischitta V, Viberti GC: Role of PC-1 gene polymorphism (K121Q) in the progression of renal disease in type 1 diabetic patients (Abstract). Diabetologia 42(Suppl. 1) A267, 1999